A reconciliation of the applicable numerators and denominators of the income statement periods presented, as reflected in the results of continuing operations, is as follows (in thousands, except per share amounts):

 

    Three Months Ended     Three Months Ended     Six Months Ended     Six Months Ended  
    June 30, 2016     June 30, 2015     June 30, 2016     June 30, 2015  
    Loss     Shares     EPS     Loss     Shares     EPS     Loss     Shares     EPS     Loss     Shares     EPS  
Basic loss per share   $ (1,127 )     17,081     $ (0.06 )   $ (1,566 )     16,020     $ (0.10 )   $ (2,463 )     17,081     $ (0.14 )   $ (2,946 )     15,956     $ (0.18 )
                                                                                                 
Dilutives:                                                                                                
Options     -       -       -       -       -       -       -       -       -       -       -       -  
                                                                                                 
Diluted loss per share   $ (1,127 )     17,081     $ (0.06 )   $ (1,566 )     16,020     $ (0.10 )   $ (2,463 )     17,081     $ (0.14 )   $ (2,946 )     15,956     $ (0.18 )

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever ProPhase Labs makes a similar move, sign up!

Other recent filings from the company include the following:

Tender offer statement by Issuer - Nov. 20, 2017
Prophase Labs Reports Financial Results - Nov. 13, 2017
ProPhase Labs Just Filed Its Quarterly Report: Note 8 – Earnings (... - Nov. 13, 2017

Auto Refresh

Feedback